Skip to main content
. 2024 Oct 28;25(21):11560. doi: 10.3390/ijms252111560

Figure 1.

Figure 1

Current trends in immunotherapy in pancreatic cancer. The solid line indicates the trials with a completed status on ClinicalTrials.gov, and the dashed line represents the trials with an active status on ClinicalTrials.gov as of August 2024.